BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 19556022)

  • 1. Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial.
    Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Ciammella P; Franco P; Mantovani C; Borasio P; Scagliotti GV; Ragona R
    Lung Cancer; 2010 Apr; 68(1):72-7. PubMed ID: 19556022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.
    Salazar OM; Sandhu TS; Lattin PB; Chang JH; Lee CK; Groshko GA; Lattin CJ
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):707-15. PubMed ID: 18455322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study.
    Baumann P; Nyman J; Hoyer M; Gagliardi G; Lax I; Wennberg B; Drugge N; Ekberg L; Friesland S; Johansson KA; Lund JS; Morhed E; Nilsson K; Levin N; Paludan M; Sederholm C; Traberg A; Wittgren L; Lewensohn R
    Radiother Oncol; 2008 Sep; 88(3):359-67. PubMed ID: 18768228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer.
    Zimmermann FB; Geinitz H; Schill S; Grosu A; Schratzenstaller U; Molls M; Jeremic B
    Lung Cancer; 2005 Apr; 48(1):107-14. PubMed ID: 15777977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy.
    Onimaru R; Fujino M; Yamazaki K; Onodera Y; Taguchi H; Katoh N; Hommura F; Oizumi S; Nishimura M; Shirato H
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):374-81. PubMed ID: 18029106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries.
    Baumann P; Nyman J; Lax I; Friesland S; Hoyer M; Rehn Ericsson S; Johansson KA; Ekberg L; Morhed E; Paludan M; Wittgren L; Blomgren H; Lewensohn R
    Acta Oncol; 2006; 45(7):787-95. PubMed ID: 16982541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer--mature results for medically inoperable patients.
    Nyman J; Johansson KA; Hultén U
    Lung Cancer; 2006 Jan; 51(1):97-103. PubMed ID: 16213059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable Stage I nonsmall cell lung carcinomas.
    Fukumoto S; Shirato H; Shimzu S; Ogura S; Onimaru R; Kitamura K; Yamazaki K; Miyasaka K; Nishimura M; Dosaka-Akita H
    Cancer; 2002 Oct; 95(7):1546-53. PubMed ID: 12237924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study.
    Hata M; Tokuuye K; Kagei K; Sugahara S; Nakayama H; Fukumitsu N; Hashimoto T; Mizumoto M; Ohara K; Akine Y
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):786-93. PubMed ID: 17379439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-individualized stereotactic body radiotherapy for T1-3N0 non-small cell lung cancer: long-term results and efficacy of adjuvant chemotherapy.
    Chen Y; Guo W; Lu Y; Zou B
    Radiother Oncol; 2008 Sep; 88(3):351-8. PubMed ID: 18722684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of multifield conformal radiation therapy of nonsmall-cell lung carcinoma using multileaf collimation beams.
    Bahri S; Flickinger JC; Kalend AM; Deutsch M; Belani CP; Sciurba FC; Luketich JD; Greenberger JS
    Radiat Oncol Investig; 1999; 7(5):297-308. PubMed ID: 10580899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy.
    Baumann P; Nyman J; Hoyer M; Wennberg B; Gagliardi G; Lax I; Drugge N; Ekberg L; Friesland S; Johansson KA; Lund JA; Morhed E; Nilsson K; Levin N; Paludan M; Sederholm C; Traberg A; Wittgren L; Lewensohn R
    J Clin Oncol; 2009 Jul; 27(20):3290-6. PubMed ID: 19414667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Outcome of three-dimensional conformal radiotherapy for early stage non-small cell lung cancer patients who met or not inclusion criteria for stereotactic-body radiation therapy].
    Kołodziejczyk M; Kępka L; Tyc-Szczepaniak D; Wierzchowski M
    Pneumonol Alergol Pol; 2011; 79(5):326-36. PubMed ID: 21861256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC).
    Zimmermann FB; Geinitz H; Schill S; Thamm R; Nieder C; Schratzenstaller U; Molls M
    Acta Oncol; 2006; 45(7):796-801. PubMed ID: 16982542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of robotic stereotactic radiotherapy to peripheral stage I non-small cell lung cancer with curative intent.
    Brown WT; Wu X; Fayad F; Fowler JF; García S; Monterroso MI; de la Zerda A; Schwade JG
    Clin Oncol (R Coll Radiol); 2009 Oct; 21(8):623-31. PubMed ID: 19682875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Phase II study of synchronous three-dimensional conformal boost to the gross tumor volume for patients with unresectable Stage III non-small-cell lung cancer: results of Korean Radiation Oncology Group 0301 study.
    Cho KH; Ahn SJ; Pyo HR; Kim KS; Kim YC; Moon SH; Han JY; Kim HT; Koom WS; Lee JS
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1397-404. PubMed ID: 19117690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the pattern of failure is distant.
    Bradley JD; El Naqa I; Drzymala RE; Trovo M; Jones G; Denning MD
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1146-50. PubMed ID: 19800181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of high-dose conformal radiotherapy for patients with medically inoperable T1-3N0 non-small-cell lung cancer: is low incidence of regional failure due to incidental nodal irradiation?
    Chen M; Hayman JA; Ten Haken RK; Tatro D; Fernando S; Kong FM
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):120-6. PubMed ID: 16198503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer.
    Liao Z; Komaki R; Milas L; Yuan C; Kies M; Chang JY; Jeter M; Guerrero T; Blumenschien G; Smith CM; Fossella F; Brown B; Cox JD
    Clin Cancer Res; 2005 May; 11(9):3342-8. PubMed ID: 15867233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer.
    Xia T; Li H; Sun Q; Wang Y; Fan N; Yu Y; Li P; Chang JY
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):117-25. PubMed ID: 16765528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.